Lixte Biotechnology【LIXT】銘柄情報

Lixte Biotechnology Holdings Inc (LIXT) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

6.19

( -14.62% )

買値

6.18

売値

7.00

出来高

871,835

5.875 日の範囲 7.11

0.64 52 週間の範囲 7.51

時価総額

71.915M

前日終値

7.25

始値

7.11

時刻

6.23

最終取引時間

財務取引量

US$ 5,556,818

VWAP

6.3737

平均取引量 (3 か月)

US$ 44,967

発行済株式数

11,617,944

配当利回り

PER

-4.78

1 株当たり利益 (EPS)

-1.05

歳入

純利益

-7.22M

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with A... Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company’s LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Boca Raton, Florida. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

lixte.com

本社

Boca Raton, United States

設立

2026

Lixte Biotechnology Holdings Inc is listed in the Healthcare sector of the ナスダック市場 with ticker LIXT. The last closing price for Lixte Biotechnology was US$7.25. Over the last year, Lixte Biotechnology shares have traded in a share price range of US$ 0.64 to US$ 7.51.

Lixte Biotechnology currently has 11,617,944 shares in issue. The market capitalisation of Lixte Biotechnology is US$71.92 million. Lixte Biotechnology has a price to earnings ratio (PE ratio) of -4.78.

The New Bottleneck Isn’t Computing Power — It’s Just Power

Issued on behalf of LIXTE Biotechnology Holdings, Inc. America can build data centers in months, but the...

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch PR Newswire BOCA RATON, Fla...

LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)

Company to be Renamed NOMAD Power Solutions • First-to-Market with the Mobile, Utility-Grade 1 MW BESS •...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Announcement Follows the Recent Appointment of Denham Capital Founder Stuart D. Porter — a Three-Decade Energy...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.64	-9.37042459736	6.83	7.51	6.05	291110	6.93804963	CS
4	0.75	13.7867647059	5.44	7.51	4.07	221873	6.64850174	CS
12	3.225	108.768971332	2.965	7.51	2.6	109365	5.71626405	CS
26	2.07	50.2427184466	4.12	7.51	2.36	87946	4.78545112	CS
52	4.93	391.26984127	1.26	7.51	0.64	598838	2.78540432	CS
156	1.11	21.8503937008	5.08	9.5	0.64	324750	2.84650809	CS
260	3.14	102.950819672	3.05	9.5	0.432	588231	2.19543039	CS